Results 11 to 20 of about 35,027 (157)

Clinical Predictors and Risk Factors of Gleason Score Upgrade: A Retrospective Cohort Analysis [PDF]

Diagnostics
Background: In prostate cancer (PCa) patients, discrepancies between biopsy-assigned Gleason Scores and those determined from surgical specimens are frequently reported. This phenomenon, known as Gleason score upgrade (GSU), can have significant clinical
Carmine Sciorio, Riccardo Giannella, Lorenzo Romano, Benito Fabio Mirto, Antonio Di Girolamo, Antonio Ruffo, Giuseppe Romeo, Fabio Esposito, Felice Crocetto, Luigi Napolitano, Raffaele Balsamo, Francesco Trama, Francesco Bottone, Carmelo Quattrone, Vittorio Imperatore, Lorenzo Spirito   +15 more
doaj   +2 more sources

Nomograms Predict Survival Advantages of Gleason Score 3+4 Over 4+3 for Prostate Cancer: A SEER-Based Study

Frontiers in Oncology, 2019
Background: Different proportions of Gleason pattern 3 and Gleason pattern 4 lead to various prognosis of prostate cancer with Gleason score 7. The objective of this study was to compare the survival outcomes of Gleason score 3+4 and 4+3 based on data ...
Xin Zhu, Xin Gou, Zhu Xin
exaly   +3 more sources

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy [PDF]

Diagnostics, 2021
Background: The impact of MRI-lesion targeted (TB) and systematic biopsy (SB) Gleason score (GS) as a predictor for final pathological GS still remains unclear. Methods: All patients with TB + SB, and subsequent radical prostatectomy (RP) between 01/2014-
Mike Wenzel, Felix Preisser, Clarissa Wittler, Benedikt Hoeh, Peter J. Wild, Alexandra Tschäbunin, Boris Bodelle, Christoph Würnschimmel, Derya Tilki, Markus Graefen, Andreas Becker, Pierre I Karakiewicz, Felix K. H. Chun, Luis A Kluth, Jens Köllermann, Philipp Mandel   +15 more
doaj   +2 more sources

Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis

Frontiers in Oncology, 2018
Purpose: Use of quantitative imaging features and encoding the intra-tumoral heterogeneity from multi-parametric magnetic resonance imaging (mpMRI) for the prediction of Gleason score is gaining attention as a non-invasive biomarker for prostate cancer ...
Ahmad Chaddad, Tamim Niazi, Stephan Probst   +2 more
exaly   +3 more sources

Interobserver agreement of gleason score and modified gleason score in needle biopsy and in surgical specimen of prostate cancer

International Brazilian Journal of Urology, 2007
INTRODUCTION: Gleason score, which has a high interobserver variability, is used to classify prostate cancer. The most recent consensus valued the tertiary Gleason pattern and recommended its use in the final score of needle biopsies (modified Gleason ...
Sergio G. Veloso, Mario F. Lima, Paulo G. Salles, Cynthia K. Berenstein, Joao D. Scalon, Eduardo A. Bambirra   +5 more
doaj   +5 more sources

Gleason score 6: Overdiagnosis and overtreatment?

Asian Journal of Surgery, 2023
Yaxiong Tang, Xu Hu, Yaohui Wang, Xiang Li   +3 more
doaj   +3 more sources

Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy

Diagnostics, 2020
Biopsy proven Gleason score is essential to decide treatment modalities for prostate cancer, either surgical (radical prostatectomy) or non-surgical (active surveillance, watchful waiting, radiation therapy and hormone therapy). Several studies indicated
Vincenzo Fiorentino, Maurizio Martini, Marco Dell’Aquila, Teresa Musarra, Ersilia Orticelli, Luigi Maria Larocca, Ernesto Rossi, Angelo Totaro, Francesco Pinto, Niccolò Lenci, Valerio Di Paola, Riccardo Manfredi, Pier Francesco Bassi, Francesco Pierconti   +13 more
doaj   +1 more source

Association of BMI and Age with Gleason Score and PSA in Patients with Prostate Cancer [PDF]

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2023
Background and Objective: Obesity has produced conflicting results on various indices of prostate cancer diagnosis. Since the effect of body mass index (BMI) on Gleason score and prostate specific antigen (PSA) as well as the overall classified risk of ...
SA Mazloumi, E Moudi, H Shafi, H Gholinia   +3 more
doaj  

The highest percentage of Gleason Pattern 4 is a predictor in intermediate‐risk prostate cancer

BJUI Compass, 2023
Objectives This study aims to clarify the clinicopathological significance of several novel pathological markers, including the percentage of Gleason pattern 4 and small/non‐small cribriform pattern, in intermediate‐risk Gleason score 3 + 4 = 7 prostate ...
Shun Sato, Takahiro Kimura, Hajime Onuma, Shin Egawa, Masayuki Shimoda, Hiroyuki Takahashi   +5 more
doaj   +1 more source

Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy

International Brazilian Journal of Urology, 2008
OBJECTIVE: There is evidence showing that Gleason grading of prostatic adenocarcinoma is one of the most powerful predictors of biological behavior and one of the most influential factors used to determine treatment for prostate cancer.
Marbele S. Guimaraes, Maisa M. Quintal, Luciana R. Meirelles, Luis A. Magna, Ubirajara Ferreira, Athanase Billis   +5 more
doaj   +1 more source